MECHANISM OF ACTION
Felbamate may inhibit the metabolism of valproic acid.
DISCUSSION
Administration of felbamate to 10 epileptic patients stabilized
on valproic acid resulted in a dose related increase in felbamate
area-under-curve (AUC) and maximum concentration (Cmax).(2)
CLINICAL EFFECTS
The addition of felbamate may result in elevated levels
and toxicity from valproic acid.(1,2)
SEVERITY LEVEL
3-Moderate Interaction: Assess the risk to the patient and
take action as needed.
PATIENT MANAGEMENT
The US manufacturer of felbamate recommends decreasing
the dosage of valproic acid by 20% during the initiation of felbamate
therapy.(1)
PREDISPOSING FACTORS
None determined.
REFERENCES